Skip to main content
Top
Published in: Antimicrobial Resistance & Infection Control 1/2018

Open Access 01-12-2018 | Review

Rationale and development of a business case for antimicrobial stewardship programs in acute care hospital settings

Authors: A. M. Morris, E. Rennert-May, B. Dalton, N. Daneman, L. Dresser, S. Fanella, J. Grant, Y. Keynan, N. Le Saux, J. McDonald, Y. Shevchuk, D. Thirion, J. M. Conly

Published in: Antimicrobial Resistance & Infection Control | Issue 1/2018

Login to get access

Abstract

Background

Antimicrobial stewardship programs (ASPs) have been shown to reduce inappropriate antimicrobial use and its consequences. However, these programs lack legislative requirements in many places and it can be difficult to determine what human resources are required for these programs and how to create a business case to present to hospital administrators for program funding. The objectives of the current paper were to review legislative requirements and outline human resource requirements for ASPs, and to create a base business case for ASPs.

Methods

A working group of antimicrobial stewardship experts from across Canada met to discuss the necessary components for creation of a business case for antimicrobial stewardship. A narrative review of the literature of the regulatory requirements and human resource recommendations for ASPs was conducted. Informed by the review and using a consensus decision-making process, the expert working group developed human resource recommendations based on a 1000 bed acute care health care facility in Canada. A spreadsheet based business case model for ASPs was also created.

Results

Legislative and /or regulatory requirements for ASPs were found in 2 countries and one state jurisdiction. The literature review and consensus development process recommended the following minimum human resources complement: 1 physician, 3 pharmacists, 0.5 program administrative and coordination support, and 0.4 data analyst support as full time equivalents (FTEs) per 1000 acute care beds. Necessary components for the business case model, including the human resource requirements, were determined to create a spreadsheet based model.

Conclusions

There is evidence to support the negative outcomes of inappropriate antimicrobial use as well as the benefits of ASPs. Legislative and /or regulatory requirements for ASPs are not common. The available evidence for human resource recommendations for ASPs using a narrative review process was examined and a base business case modelling scenario was created. As regulatory requirements for ASPs increase, it will be necessary to create accurate business cases for ASPs in order to obtain the necessary funding to render these programs successful.
Appendix
Available only for authorised users
Literature
1.
go back to reference Armstrong GL, Conn LA, Pinner RW. Trends in infectious disease mortality in the United States during the 20th century. JAMA. 1999;281(1):61–6.CrossRefPubMed Armstrong GL, Conn LA, Pinner RW. Trends in infectious disease mortality in the United States during the 20th century. JAMA. 1999;281(1):61–6.CrossRefPubMed
2.
go back to reference Novotny J, Novotny M. Adverse drug reactions to antibiotics and major antibiotic drug interactions. Gen Physiol Biophys. 1999;18 Spec No:126–39.PubMed Novotny J, Novotny M. Adverse drug reactions to antibiotics and major antibiotic drug interactions. Gen Physiol Biophys. 1999;18 Spec No:126–39.PubMed
3.
go back to reference Zed PJ, Abu-Laban RB, Balen RM, Loewen P, Hohl C, Brubacher J, et al. Incidence, severity and preventability of medication-related visits to the emergency department: a prospective study. CMAJ. 2008;178(12):1563–9.CrossRefPubMedPubMedCentral Zed PJ, Abu-Laban RB, Balen RM, Loewen P, Hohl C, Brubacher J, et al. Incidence, severity and preventability of medication-related visits to the emergency department: a prospective study. CMAJ. 2008;178(12):1563–9.CrossRefPubMedPubMedCentral
5.
go back to reference Rahal JJ, Urban C, Horn D, Freeman K, Segal-Maurer S, Maurer J, et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA. 1998;280(14):1233–7.CrossRefPubMed Rahal JJ, Urban C, Horn D, Freeman K, Segal-Maurer S, Maurer J, et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA. 1998;280(14):1233–7.CrossRefPubMed
6.
go back to reference Meyer E, Gastmeier P, Deja M, Schwab F. Antibiotic consumption and resistance: data from Europe and Germany. Int J Med Microbiol. 2013;303(6–7):388–95.CrossRefPubMed Meyer E, Gastmeier P, Deja M, Schwab F. Antibiotic consumption and resistance: data from Europe and Germany. Int J Med Microbiol. 2013;303(6–7):388–95.CrossRefPubMed
7.
go back to reference MacDougall C, Powell JP, Johnson CK, Edmond MB, Polk RE. Hospital and community fluoroquinolone use and resistance in Staphylococcus aureus and Escherichia coli in 17 US hospitals. Clin Infect Dis. 2005;41(4):435–40.CrossRefPubMed MacDougall C, Powell JP, Johnson CK, Edmond MB, Polk RE. Hospital and community fluoroquinolone use and resistance in Staphylococcus aureus and Escherichia coli in 17 US hospitals. Clin Infect Dis. 2005;41(4):435–40.CrossRefPubMed
8.
go back to reference Carignan A, Roussy JF, Lapointe V, Valiquette L, Sabbagh R, Pepin J. Increasing risk of infectious complications after transrectal ultrasound-guided prostate biopsies: time to reassess antimicrobial prophylaxis? Eur Urol. 2012;62(3):453–9.CrossRefPubMed Carignan A, Roussy JF, Lapointe V, Valiquette L, Sabbagh R, Pepin J. Increasing risk of infectious complications after transrectal ultrasound-guided prostate biopsies: time to reassess antimicrobial prophylaxis? Eur Urol. 2012;62(3):453–9.CrossRefPubMed
9.
go back to reference Demczuk W, Martin I, Peterson S, Bharat A, Van Domselaar G, Graham M, et al. Genomic epidemiology and molecular resistance mechanisms of azithromycin-resistant Neisseria gonorrhoeae in Canada from 1997 to 2014. J Clin Microbiol. 2016;54(5):1304–13.CrossRefPubMedPubMedCentral Demczuk W, Martin I, Peterson S, Bharat A, Van Domselaar G, Graham M, et al. Genomic epidemiology and molecular resistance mechanisms of azithromycin-resistant Neisseria gonorrhoeae in Canada from 1997 to 2014. J Clin Microbiol. 2016;54(5):1304–13.CrossRefPubMedPubMedCentral
10.
go back to reference Schuts EC, Hulscher ME, Mouton JW, Verduin C, Stuart J, Overdiek H, et al. Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis. Lancet Infect Dis. 2016;16(7):847–56.CrossRefPubMed Schuts EC, Hulscher ME, Mouton JW, Verduin C, Stuart J, Overdiek H, et al. Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis. Lancet Infect Dis. 2016;16(7):847–56.CrossRefPubMed
11.
go back to reference Karanika S, Paudel S, Grigoras C, Kalbasi A, Mylonakis E. Systematic review and meta-analysis of clinical and economic outcomes from the implementation of hospital-based antimicrobial stewardship programs. Antimicrob Agents Chemother. 2016;60(8):4840–52.CrossRefPubMedPubMedCentral Karanika S, Paudel S, Grigoras C, Kalbasi A, Mylonakis E. Systematic review and meta-analysis of clinical and economic outcomes from the implementation of hospital-based antimicrobial stewardship programs. Antimicrob Agents Chemother. 2016;60(8):4840–52.CrossRefPubMedPubMedCentral
14.
go back to reference Accreditation Canada. Required organization practices handbook. Ottawa: Accrediation Canada; 2015. Accreditation Canada. Required organization practices handbook. Ottawa: Accrediation Canada; 2015.
18.
go back to reference Le Coz P, Carlet J, Roblot F, Pulcini C. Human resources needed to perform antimicrobial stewardship teams’ activities in French hospitals. Med Mal Infect. 2016;46(4):200–6.CrossRefPubMed Le Coz P, Carlet J, Roblot F, Pulcini C. Human resources needed to perform antimicrobial stewardship teams’ activities in French hospitals. Med Mal Infect. 2016;46(4):200–6.CrossRefPubMed
19.
go back to reference Goff DA, Kullar R, Bauer KA, File TM Jr. Eight habits of highly effective antimicrobial stewardship programs to meet the joint commission standards for hospitals. Clin Infect Dis. 2017;64(8):1134–9.CrossRefPubMed Goff DA, Kullar R, Bauer KA, File TM Jr. Eight habits of highly effective antimicrobial stewardship programs to meet the joint commission standards for hospitals. Clin Infect Dis. 2017;64(8):1134–9.CrossRefPubMed
20.
go back to reference Pulcini C, Morel CM, Tacconelli E, Beovic B, de With K, Goossens H, et al. Human resources estimates and funding for antibiotic stewardship teams are urgently needed. Clin Microbiol Infect. 2017;23(11):785–7.CrossRefPubMed Pulcini C, Morel CM, Tacconelli E, Beovic B, de With K, Goossens H, et al. Human resources estimates and funding for antibiotic stewardship teams are urgently needed. Clin Microbiol Infect. 2017;23(11):785–7.CrossRefPubMed
21.
go back to reference Hughes JM. Study on the efficacy of nosocomial infection control (SENIC project): results and implications for the future. Chemotherapy. 1988;34(6):553–61.CrossRefPubMed Hughes JM. Study on the efficacy of nosocomial infection control (SENIC project): results and implications for the future. Chemotherapy. 1988;34(6):553–61.CrossRefPubMed
22.
go back to reference O'Boyle C, Jackson M, Henly SJ. Staffing requirements for infection control programs in US health care facilities: Delphi project. Am J Infect Control. 2002;30(6):321–33.CrossRefPubMed O'Boyle C, Jackson M, Henly SJ. Staffing requirements for infection control programs in US health care facilities: Delphi project. Am J Infect Control. 2002;30(6):321–33.CrossRefPubMed
25.
go back to reference Spellberg B, Bartlett JG, Gilbert DN. How to pitch an antibiotic stewardship program to hosptial c-suite. Open Forum Infec Dis. 2016;3(4):ofw210.CrossRef Spellberg B, Bartlett JG, Gilbert DN. How to pitch an antibiotic stewardship program to hosptial c-suite. Open Forum Infec Dis. 2016;3(4):ofw210.CrossRef
26.
go back to reference van den Bosch CM, Hulscher ME, Natsch S, Wille J, Prins JM, Geerlings SE. Applicability of generic quality indicators for appropriate antibiotic use in daily hospital practice: a cross-sectional point-prevalence multicenter study. Clin Microbiol Infect. 2016;22(10):888.e1–9.CrossRefPubMed van den Bosch CM, Hulscher ME, Natsch S, Wille J, Prins JM, Geerlings SE. Applicability of generic quality indicators for appropriate antibiotic use in daily hospital practice: a cross-sectional point-prevalence multicenter study. Clin Microbiol Infect. 2016;22(10):888.e1–9.CrossRefPubMed
Metadata
Title
Rationale and development of a business case for antimicrobial stewardship programs in acute care hospital settings
Authors
A. M. Morris
E. Rennert-May
B. Dalton
N. Daneman
L. Dresser
S. Fanella
J. Grant
Y. Keynan
N. Le Saux
J. McDonald
Y. Shevchuk
D. Thirion
J. M. Conly
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Antimicrobial Resistance & Infection Control / Issue 1/2018
Electronic ISSN: 2047-2994
DOI
https://doi.org/10.1186/s13756-018-0396-z

Other articles of this Issue 1/2018

Antimicrobial Resistance & Infection Control 1/2018 Go to the issue